PRESS RELEASE published on 01/25/2024 at 14:03, 1 year 10 months ago BioAdaptives' Subsidiary, Livestock Impact, Inc., Celebrates Banner 2023 Equine Championship Titles Attributed to Its Advanced Proprietary Supplement Products BioAdaptives Inc. celebrates the achievement of multiple Equine Championship Titles attributed to its subsidiary Livestock Impact, Inc.'s advanced proprietary supplements. The highlight was the spectacular performance of Cheyanne Colclasure with her 23-year-old horse, Docs Dual Quixote, who secured the 35,000 Non Pro National Championship Title at the 2023 United States Cutting Horse Association (USCHA) National Championship competition. Livestock Impact's All-In-One supplement formulas have shown rejuvenating effects such as improved energy, agility, and response time in animals. BioAdaptives, Inc. manufactures and distributes natural plant- and algal-based products that improve health and wellness for humans and animals, with an emphasis on pain relief, antiviral activity, immune system defense, resistance to stress, endurance, recovery, and anti-aging properties. The company's products for horses and dogs provide general health, competitive performance enhancement, rejuvenation effects, and pain relief, as well as improvements in appearance. BioAdaptives Inc. Livestock Impact Equine Championship Titles Proprietary Supplements All-natural Dietary Supplements
PRESS RELEASE published on 10/10/2023 at 14:30, 2 years 1 month ago BioAdaptives Announces Nationwide Launch of Lung Fortress(TM) Natural Supplement
Published on 12/05/2025 at 02:35, 4 hours 19 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 54 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 49 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 54 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 24 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 3 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 29 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 39 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 43 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 54 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 9 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 10 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 53 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
